Atomistry » Vanadium » PDB 1z12-3myh » 2i4e
Atomistry »
  Vanadium »
    PDB 1z12-3myh »
      2i4e »

Vanadium in PDB 2i4e: Structural Studies of Protein Tyrosine Phosphatase Beta Catalytic Domain in Complex with Inhibitors

Enzymatic activity of Structural Studies of Protein Tyrosine Phosphatase Beta Catalytic Domain in Complex with Inhibitors

All present enzymatic activity of Structural Studies of Protein Tyrosine Phosphatase Beta Catalytic Domain in Complex with Inhibitors:
3.1.3.48;

Protein crystallography data

The structure of Structural Studies of Protein Tyrosine Phosphatase Beta Catalytic Domain in Complex with Inhibitors, PDB code: 2i4e was solved by A.G.Evdokimov, M.E.Pokross, R.L.Walter, M.Mekel, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 38.10 / 1.75
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 62.058, 71.721, 69.859, 90.00, 93.31, 90.00
R / Rfree (%) 18.3 / 22.1

Vanadium Binding Sites:

The binding sites of Vanadium atom in the Structural Studies of Protein Tyrosine Phosphatase Beta Catalytic Domain in Complex with Inhibitors (pdb code 2i4e). This binding sites where shown within 5.0 Angstroms radius around Vanadium atom.
In total 2 binding sites of Vanadium where determined in the Structural Studies of Protein Tyrosine Phosphatase Beta Catalytic Domain in Complex with Inhibitors, PDB code: 2i4e:
Jump to Vanadium binding site number: 1; 2;

Vanadium binding site 1 out of 2 in 2i4e

Go back to Vanadium Binding Sites List in 2i4e
Vanadium binding site 1 out of 2 in the Structural Studies of Protein Tyrosine Phosphatase Beta Catalytic Domain in Complex with Inhibitors


Mono view


Stereo pair view

A full contact list of Vanadium with other atoms in the V binding site number 1 of Structural Studies of Protein Tyrosine Phosphatase Beta Catalytic Domain in Complex with Inhibitors within 5.0Å range:
probe atom residue distance (Å) B Occ
A:V1

b:20.1
occ:1.00
V A:VO41 0.0 20.1 1.0
O3 A:VO41 1.7 20.5 1.0
O1 A:VO41 1.7 20.2 1.0
O2 A:VO41 1.8 19.1 1.0
O4 A:VO41 2.0 20.8 1.0
SG A:CYS1904 2.5 17.8 1.0
CB A:CYS1904 3.5 17.1 1.0
OD2 A:ASP1870 3.8 27.3 1.0
N A:GLY1909 3.8 17.6 1.0
N A:ALA1906 3.8 16.6 1.0
NE A:ARG1910 3.9 21.0 1.0
O A:HOH43 4.0 24.8 1.0
NH2 A:ARG1910 4.0 19.1 1.0
N A:SER1905 4.0 16.3 1.0
N A:ARG1910 4.0 17.3 1.0
O A:HOH155 4.1 35.2 1.0
NE2 A:GLN1948 4.1 18.8 1.0
N A:GLY1907 4.2 17.4 1.0
N A:VAL1908 4.3 16.7 1.0
CA A:GLY1909 4.4 19.8 1.0
CB A:ALA1906 4.4 19.8 1.0
CZ A:ARG1910 4.5 23.1 1.0
CA A:ALA1906 4.6 15.9 1.0
CG A:ASP1870 4.6 25.4 1.0
CB A:ARG1910 4.7 19.0 1.0
CA A:CYS1904 4.7 16.2 1.0
C A:GLY1909 4.7 17.2 1.0
C A:SER1905 4.8 15.3 1.0
CA A:SER1905 4.8 16.1 1.0
C A:ALA1906 4.8 17.9 1.0
C A:CYS1904 4.8 16.6 1.0
CG A:ARG1910 4.8 17.5 1.0
C A:VAL1908 4.8 18.0 1.0
CB A:SER1905 4.9 16.5 1.0
CA A:GLY1907 4.9 17.5 1.0
OD1 A:ASP1870 4.9 27.8 1.0
CG2 A:VAL1908 4.9 20.5 1.0
CA A:ARG1910 5.0 16.3 1.0

Vanadium binding site 2 out of 2 in 2i4e

Go back to Vanadium Binding Sites List in 2i4e
Vanadium binding site 2 out of 2 in the Structural Studies of Protein Tyrosine Phosphatase Beta Catalytic Domain in Complex with Inhibitors


Mono view


Stereo pair view

A full contact list of Vanadium with other atoms in the V binding site number 2 of Structural Studies of Protein Tyrosine Phosphatase Beta Catalytic Domain in Complex with Inhibitors within 5.0Å range:
probe atom residue distance (Å) B Occ
B:V2

b:23.6
occ:1.00
V B:VO42 0.0 23.6 1.0
O2 B:VO42 1.7 22.7 1.0
O1 B:VO42 1.7 25.4 1.0
O3 B:VO42 1.8 23.2 1.0
O4 B:VO42 2.0 25.7 1.0
SG B:CYS1904 2.5 21.7 1.0
CB B:CYS1904 3.5 21.1 1.0
OD1 B:ASP1870 3.8 31.6 1.0
N B:GLY1909 3.8 20.6 1.0
N B:ALA1906 3.8 20.5 1.0
NE B:ARG1910 3.9 24.9 1.0
O B:HOH98 4.0 28.9 1.0
N B:ARG1910 4.0 22.6 1.0
NH2 B:ARG1910 4.0 22.2 1.0
N B:SER1905 4.0 18.1 1.0
NE2 B:GLN1948 4.1 23.2 1.0
N B:GLY1907 4.2 19.6 1.0
O B:HOH84 4.2 40.6 1.0
N B:VAL1908 4.3 21.0 1.0
CB B:ALA1906 4.3 21.0 1.0
CA B:GLY1909 4.3 23.4 1.0
CZ B:ARG1910 4.5 22.8 1.0
CA B:ALA1906 4.5 21.6 1.0
CG B:ASP1870 4.6 28.7 1.0
C B:GLY1909 4.7 20.1 1.0
CB B:ARG1910 4.7 21.1 1.0
CA B:CYS1904 4.7 19.8 1.0
C B:ALA1906 4.8 21.3 1.0
C B:SER1905 4.8 18.1 1.0
CA B:SER1905 4.8 18.6 1.0
CG B:ARG1910 4.8 20.3 1.0
C B:VAL1908 4.8 23.4 1.0
C B:CYS1904 4.8 21.1 1.0
CB B:SER1905 4.9 18.4 1.0
CG2 B:VAL1908 4.9 23.8 1.0
OD2 B:ASP1870 4.9 31.0 1.0
CD B:ARG1910 5.0 20.5 1.0
CA B:ARG1910 5.0 19.3 1.0

Reference:

A.G.Evdokimov, M.Pokross, R.Walter, M.Mekel, B.Cox, C.Li, R.Bechard, F.Genbauffe, R.Andrews, C.Diven, B.Howard, V.Rastogi, J.Gray, M.Maier, K.G.Peters. Engineering the Catalytic Domain of Human Protein Tyrosine Phosphatase Beta For Structure-Based Drug Discovery. Acta Crystallogr.,Sect.D V. 62 1435 2006.
ISSN: ISSN 0907-4449
PubMed: 17139078
DOI: 10.1107/S0907444906037784
Page generated: Thu Oct 29 07:04:49 2020

Last articles

Xe in 6AYK
Xe in 6QII
Xe in 6ASM
Xe in 5NSW
Xe in 6FY9
Xe in 5O1K
Xe in 5O27
Xe in 5M69
Xe in 5KPU
Xe in 5I63
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy